Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux for VTE Prevention in CABG Patients
NCT00789399Phase 2Terminated
- Sponsor
- Prairie Education and Research Cooperative
- Start
- Nov 2009
- Primary completion
- Sep 2013
- Modality
- Allosteric Modulators
01
Overview
A Phase 2 trial of fondaparinux in venous thromboembolism (VTE), sponsored by Prairie Education and Research Cooperative. Started Nov 2009; status: terminated.
02
Drugs
fondaparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00789399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789399.